Morgan Stanley Issues $1.27 Billion Fixed Rate Notes Due 2032 at 4.700% Annual Interest

Overview of Morgan Stanley's Debt Issuance Terms and Structure

Morgan Stanley has issued fixed rate notes with a total aggregate principal amount of $1.27 billion. Each note carries a stated principal amount of $1,000 and was issued at $1,000 per note to investors purchasing through regular channels. The notes represent direct unsecured obligations of Morgan Stanley, a major global investment bank and financial services firm that operates across wealth management, investment banking, sales and trading, and asset management businesses. The company did not disclose specific financial metrics or operational results in this debt pricing announcement.

The pricing supplement indicates that the notes mature on July 20, 2032, providing a six-year investment horizon for debt holders. Interest accrual commenced on the original issue date of July 20, 2026, with the first interest payment scheduled for January 20, 2027. The semi-annual interest payment schedule means investors will receive coupon payments on the 20th calendar day of January and July each year through maturity, subject to adjustment if such dates fall on non-business days. The day-count convention used is the 30/360 bond basis method, a standard calculation method in fixed income markets.

Interest Rate Determination and Economic Terms of the Notes

The notes bear an annual interest rate of 4.700% per annum, payable in semi-annual installments. The disclosure states that in determining this economic rate, Morgan Stanley used an internal funding rate that the company indicates is likely to be lower than its secondary market credit spreads. This internal funding rate is explicitly noted as advantageous to the issuer rather than to note investors. The filing explains that if the issuing, selling, structuring, and hedging costs borne by investors were lower, or if the internal funding rate were higher, the economic terms would be more favorable to note purchasers.

The valuation methodology employed by Morgan Stanley incorporates both a debt component and a performance-based component linked to interest rates. The company's pricing and valuation models factor in market inputs, assumptions relating to volatility, current and expected interest rates, and an interest rate related to the secondary market credit spread. The estimated value per note on the pricing date of July 16, 2026, was $973.70, which reflects the difference between the $1,000 issue price and the embedded costs of issuance and structuring. This $26.30 per note discount illustrates the price impact of distribution expenses borne by investors at purchase.

Pricing, Commissions, and Distribution Arrangements

The pricing supplement discloses that the price to public for investors purchasing notes in regular accounts was $1,000 per note, while investors utilizing fee-based advisory accounts were charged a reduced price of $990 per note, reflecting the elimination of commissions in advisory structures. The agent, Morgan Stanley & Co. LLC, a wholly owned subsidiary of Morgan Stanley, received fixed sales commissions of $10 per note from dealers and financial advisors, except in the case of notes sold to investors in fee-based advisory accounts, where no sales commission was paid. This arrangement resulted in total agent commissions of $12.7 million on the aggregate $1.27 billion issuance.

The net proceeds to Morgan Stanley issuer after deduction of the $12.7 million in agent commissions totaled $1.257 billion. The structure highlights that dealers and financial advisors, including Morgan Stanley Wealth Management, which is an affiliate of the distribution agent, collectively received commission compensation for distribution activities. The pricing supplement specifically notes that MS & Co., the subsidiary agent, may or may not make a market in the notes following issuance and retains the right to cease market-making activities at any time, providing no guarantee of secondary market liquidity for investors.

Credit Risk and Investor Dependence on Morgan Stanley Creditworthiness

All payments on the notes are expressly subject to the credit risk of Morgan Stanley. The pricing supplement emphasizes that investors are entirely dependent on the company's ability to pay all interest due on scheduled payment dates and the full principal amount at maturity. The notes are unsecured obligations, meaning they are not backed by any collateral or security interest in assets, and are not guaranteed by any other entity or subsidiary. If Morgan Stanley defaults on its obligations under the notes, the disclosure explicitly states that investors could lose some or all of their investment.

The document identifies that the market value of the notes prior to maturity will be materially affected by changes in market perception of Morgan Stanley's creditworthiness. Any actual or anticipated decline in the company's credit ratings or any increase in credit spreads charged by the market for assuming Morgan Stanley credit risk would likely adversely affect the value of the notes. Investors bear the full extent of this credit risk, with no mitigation mechanisms or guarantees specified in the terms disclosed.

Secondary Market Pricing and Liquidity Considerations

The estimated value on the pricing date of $973.70 per note may differ from secondary market pricing due to several factors that Morgan Stanley's subsidiary agent would consider when purchasing notes in secondary transactions. The price at which MS & Co. would purchase notes in the secondary market, absent changes in market conditions related to interest rates or other variables, may be lower than the estimated pricing date value because secondary market pricing incorporates the company's secondary market credit spread as well as the bid-offer spread that the agent would charge for executing such transactions. Additionally, secondary market prices would reflect the costs of unwinding related hedging transactions and other operational factors.

The pricing supplement explicitly states that MS & Co. may elect not to make a market in the notes and, if it chooses to do so, retains the right to cease market-making activities at any time without notice or obligation. This provision means investors cannot rely on an active secondary market or liquidity at any specified bid-ask spread. The document cautions that depending on actual or anticipated levels of interest and yield rates, the market value of the notes is expected to decrease, and investors may receive substantially less than the 100% of the original issue price if they attempt to sell prior to maturity.

Valuation Methodology and Pricing Assumptions

Morgan Stanley's valuation of the notes incorporates both the debt component reflecting the time value of money and credit risk, as well as a performance-based component tied to interest rate movements. The company discloses that it used its own internal pricing and valuation models, which incorporate market inputs and assumptions regarding volatility, current interest rates, expected future interest rates, and the secondary market credit spread at which Morgan Stanley's conventional fixed rate debt trades in secondary markets. These modeling assumptions directly influence the estimated fair value calculation that resulted in the $973.70 per note valuation.

The disclosure indicates that the difference between the $1,000 issue price and the $973.70 estimated value—a $26.30 per note markdown, or approximately 2.63%—represents the cumulative effect of issuing costs, selling commissions, structuring expenses, hedging costs, the internal funding rate advantage to the issuer, and the bid-offer spread embedded in pricing. Should these costs have been lower or the internal funding rate higher, the estimated value would have been closer to par. The methodology reflects standard practice in structured debt markets where embedded derivatives, credit risk, and distribution expenses create a discount between issue price and fair value.

Use of Proceeds and Hedging Activities

The pricing supplement references a "Use of Proceeds and Hedging" section on page 5 of the document but does not provide detailed disclosure of specific use-of-proceeds categories in the excerpt provided. The document does indicate that the $1.257 billion in net proceeds to Morgan Stanley after agent commissions represent capital that will be deployed according to the company's treasury and capital management policies. The pricing structure inherently assumes that Morgan Stanley will undertake hedging transactions to manage its interest rate and other market exposures associated with issuing these fixed rate obligations.

The reference to costs associated with hedging in the valuation analysis suggests that Morgan Stanley engaged in or anticipated hedging activities related to the interest rate risk embedded in the notes. Secondary market pricing discussions reference "the costs of unwinding the related hedging transactions," confirming that the company established hedges upon issuance. These hedging costs are borne by investors through the markdown between issue price and estimated fair value, representing an additional economic disadvantage to note holders relative to the issuer's internal funding advantages.

Structural Features and Payment Mechanics of Fixed Rate Notes

The notes are structured as fixed rate debt securities with straightforward payment mechanics. On each interest payment date—January 20 and July 20—investors will receive accrued and unpaid interest calculated using the 30/360 day-count convention at the rate of 4.700% per annum. If any scheduled payment date falls on a non-business day, the payment will be made on the next succeeding business day with no adjustment to the interest amount. At maturity on July 20, 2032, investors will receive the stated principal amount of $1,000 per note plus any final accrued and unpaid interest.

The notes are issued in book-entry form, eliminating the need for physical share certificates, and investors will hold beneficial interests through the depositary system. The CUSIP identifier assigned to the notes is 61760QXL3, with corresponding ISIN US61760QXL30, enabling identification in trading systems and databases. The notes will not be listed on any securities exchange, meaning trading, if any, will occur in the over-the-counter secondary market for corporate debt. The trustee for the notes is The Bank of New York Mellon, while Morgan Stanley Capital Services LLC serves as the calculation agent responsible for computing interest payments and other contractual calculations.

Risks Inherent in the Unsecured Debt Structure

The pricing supplement provides extensive risk disclosure, beginning with the fundamental credit risk that investors bear as unsecured creditors of Morgan Stanley. The document emphasizes that if Morgan Stanley defaults on its obligations, investors would lose some or all of their principal investment. The notes are not secured by any specific assets, provide no security interest in underlying reference assets, and carry no guarantee from any affiliated entity. This unsecured status places note holders in a subordinated position relative to any secured lenders Morgan Stanley may have in the future.

Additional risks identified include the substantial potential for market value deterioration prior to maturity based on changes in interest rates, yield curves, and market credit spreads. The longer the time remaining to maturity, the more susceptible the notes become to such market price fluctuations. The disclosure notes that factors including actual or anticipated changes in interest rates, changes in Morgan Stanley's credit ratings or credit spreads, and the time remaining to maturity will all influence secondary market pricing. In adverse rate or credit spread environments, investors could face significant losses if forced to liquidate positions before maturity.

Regulatory Status and Investor Protections

The pricing supplement includes mandatory SEC disclosure language stating that the Securities and Exchange Commission and state securities regulators have not approved or disapproved the notes, nor have they determined whether the pricing supplement or accompanying prospectus materials are truthful or complete. The document explicitly states that any representation suggesting such approval would constitute a criminal offense. This language reflects the regulatory framework governing the offer and sale of debt securities in capital markets.

The document also clarifies important limitations on investor protections. The notes are explicitly identified as not being deposits or savings accounts and therefore are not insured by the Federal Deposit Insurance Corporation, the Securities Investor Protection Corporation, or any other governmental agency or instrumentality. The notes are not obligations of, or guaranteed by, a bank, even though Morgan Stanley operates banking subsidiaries and affiliates. This disclaimer ensures investors understand that standard bank deposit insurance protections do not apply to these debt securities.